The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
Open accessAbstract
Identifying effective treatment combinations for MS patients failing standard therapy is an important goal. We report the results of a phase II open label baseline-to-treatment trial of a humanized monoclonal antibody against CD25 (daclizumab) in 10 multiple sclerosis patients with incomplete response to IFN-β therapy and high brain inflammatory and clinical disease activity. Daclizumab was very well tolerated and led to a 78% reduction in new contrast-enhancing lesions and to a significant improvement in several clinical outcome measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., McDowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., & Willmon, T. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20235.x · Cited by 1,438
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., & O'Connor, P. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,242
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Self-citationProspective study on the relationship between infections and multiple sclerosis exacerbations
Buljevac, D., Flach, H. Z., Hop, W. C. J., Hijdra, D., Laman, J. D., Savelkoul, H. F. J., van der Meché, F. G. A., van Doorn, P. A., & Hintzen, R. Q. (2002) · Brain · doi:10.1093/brain/awf098 · Cited by 427
Method for Quantification of Brain, Ventricular, and Subarachnoid CSF Volumes from MR Images
DeCarli, C., Maisog, J., Murphy, D. G. M., Teichberg, D., Rapoport, S. I., & Horwitz, B. (1992) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199203000-00018 · Cited by 259
Nussenblatt, R. B., Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7462 · Cited by 259
Self-citationWebster, A. C., Playford, E. G., Higgins, G., Chapman, J. R., & Craig, J. C. (2004) · Transplantation · doi:10.1097/01.tp.0000109643.32659.c4 · Cited by 229
The use of antibodies against the IL-2 receptor in transplantation.
Waldmann, T., & O'Shea, J. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80215-x · Cited by 139
Self-citationClinical scales for multiple sclerosis
Sharrack, B., & Hughes, R. A. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00261-y · Cited by 107
A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients
Frank, J. A., Richert, N. D., Lewis, B. K., Bash, C. N., Howard, T., Civil, R. H., Stone, R. D., Eaton, J. K., McFarland, H. F., & Leist, T. P. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms768oa · Cited by 99
Self-citationCorrespondence of closest gradient Voxels—A robust registration algorithm
Ostuni, J. L., Levin, R. L., Frank, J. A., & DeCarli, C. S. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070227 · Cited by 46
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Self-citationRisk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Waldmann, T. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1901 · Cited by 1,178
Self-citationMultiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Self-citation
Metadata
- Authors
- Bielekova, B., Richert, N., Howard, T., Blevins, G., Markovic-Plese, S., McCartin, J., Würfel, J., Ohayon, J., Waldmann, T. A., McFarland, H. F., & Martin, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-05-25
- Volume
- 101
- Issue
- 23
- Pages
- 8705-8708
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1996481500
- Cited by
- 315
- References
- 13
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.